Fsd Pharma (TSE:HUGE) has released an update.
FSD Pharma has bolstered its investment in Celly Nutrition Corp., a Canadian firm set to launch unbuzzd™, a beverage designed to speed up alcohol metabolism and aid recovery from consumption. The additional $300,000 investment, raising the loan to $1.3 million, reflects FSD Pharma’s confidence in Celly Nutrition’s potential to disrupt the wellness and recovery supplement market. The funding will support the manufacturing of unbuzzd™, anticipated to hit the North American market later this summer.
For further insights into TSE:HUGE stock, check out TipRanks’ Stock Analysis page.
